Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriella Guarnieri

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Journal of Clinical Medicine|July 29, 2023
Dyspnea in Post-Acute COVID-19: A Multi-Parametric Cardiopulmonary EvaluationAntonella Cecchetto, Gabriella Guarnieri, Gianpaolo Torreggiani, et al.
La Medicina Del Lavoro|May 1, 2020
Silicosis in finishing workers in quartz conglomerates processingGabriella Guarnieri, Mauro Salasnich, Paolo Lucernoni, et al.
European Journal of Internal Medicine|January 4, 2022
Outcome of SARS CoV-2 inpatients treated with convalescent plasma: One-year of data from the Veneto region (Italy) RegistryGiustina De Silvestro, Piero Marson, Massimo La Raja, et al.
Computer Methods and Programs in Biomedicine|May 19, 2022
Time-series analysis of multidimensional clinical-laboratory data by dynamic Bayesian networks reveals trajectories of COVID-19 outcomesEnrico Longato, Mario Luca Morieri, Giovanni Sparacino, et al.
Journal of Clinical Medicine|March 10, 2022
Clinical Outcomes in Patients Aged 80 Years or Older Receiving Non-Invasive Respiratory Support for Hypoxemic Acute Respiratory Failure Consequent to COVID-19Andrea Vianello, Nello De Vita, Lorenza Scotti, et al.
Respiratory Medicine|December 1, 2020
Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severityMarco Caminati, Alessandra Vultaggio, Andrea Matucci, et al.
Allergy|July 28, 2020
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian surveyAndrea Matucci, Marco Caminati, Emanuele Vivarelli, et al.
Biomedicines|February 24, 2024
Dupilumab Efficacy on Asthma Functional, Inflammatory, and Patient-Reported Outcomes across Different Disease Phenotypes and Severity: A Real-Life PerspectiveMarco Caminati, Matteo Maule, Roberto Benoni, et al.
Respiratory Medicine|June 13, 2025
ICS use trajectories in severe asthma patients on benralizumab: real-life data from 3-years follow-upLaura Pini, Marco Caminati, Matteo Maule, et al.
Journal of Clinical Medicine|May 25, 2024
Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life StudyLaura Pini, Diego Bagnasco, Bianca Beghè, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Journal of Clinical Medicine|July 29, 2023
Dyspnea in Post-Acute COVID-19: A Multi-Parametric Cardiopulmonary EvaluationAntonella Cecchetto, Gabriella Guarnieri, Gianpaolo Torreggiani, et al.
La Medicina Del Lavoro|May 1, 2020
Silicosis in finishing workers in quartz conglomerates processingGabriella Guarnieri, Mauro Salasnich, Paolo Lucernoni, et al.
European Journal of Internal Medicine|January 4, 2022
Outcome of SARS CoV-2 inpatients treated with convalescent plasma: One-year of data from the Veneto region (Italy) RegistryGiustina De Silvestro, Piero Marson, Massimo La Raja, et al.
Computer Methods and Programs in Biomedicine|May 19, 2022
Time-series analysis of multidimensional clinical-laboratory data by dynamic Bayesian networks reveals trajectories of COVID-19 outcomesEnrico Longato, Mario Luca Morieri, Giovanni Sparacino, et al.
Journal of Clinical Medicine|March 10, 2022
Clinical Outcomes in Patients Aged 80 Years or Older Receiving Non-Invasive Respiratory Support for Hypoxemic Acute Respiratory Failure Consequent to COVID-19Andrea Vianello, Nello De Vita, Lorenza Scotti, et al.
Respiratory Medicine|December 1, 2020
Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severityMarco Caminati, Alessandra Vultaggio, Andrea Matucci, et al.
Allergy|July 28, 2020
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian surveyAndrea Matucci, Marco Caminati, Emanuele Vivarelli, et al.
Biomedicines|February 24, 2024
Dupilumab Efficacy on Asthma Functional, Inflammatory, and Patient-Reported Outcomes across Different Disease Phenotypes and Severity: A Real-Life PerspectiveMarco Caminati, Matteo Maule, Roberto Benoni, et al.
Respiratory Medicine|June 13, 2025
ICS use trajectories in severe asthma patients on benralizumab: real-life data from 3-years follow-upLaura Pini, Marco Caminati, Matteo Maule, et al.
Journal of Clinical Medicine|May 25, 2024
Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life StudyLaura Pini, Diego Bagnasco, Bianca Beghè, et al.
Pageof 8